Skip Navigation

Faculty Directory

Lois Privor-Dumm, MBA

Lois Privor-Dumm
  • Senior Research Associate

Departmental Affiliations

Center & Institute Affiliations

Contact Information

415 N. Washington Street
5th Floor
Baltimore, Maryland 21205

International Vaccine Access Center
VoICE

View Current Courses

Education

MBA, University of South Carolina, 1988

Overview

As Sr. Advisor, Policy Advocacy & Communications and Director of Adult Immunization at the International Vaccine Access Center (IVAC), I focus on immunization policy issues across the life course in a broad range of countries. My research interests include understanding of the drivers of and barriers to country policies, characterizing country archetypes, stakeholder analysis, and factors impacting national vaccine decision-making and equitable uptake, with specific focus on pneumococcal, Hib, rotavirus, influenza and COVID-19 vaccines. More recently, I've focused on community engagement and vaccine acceptance in older minority populations in Baltimore City and preparation for COVID-19 vaccines in both the US and globally. I have worked in more than 70 countries to help accelerate equitable access to new and underutilized vaccines including Hib, pneumococcal, rotavirus, influenza and COVID-19 vaccines. Much of my focus has been in large countries, including India, Nigeria, Pakistan and Indonesia to support immunization decisions and work with local stakeholders to build an enabling environment for vaccines. My advocacy work focuses on both the broader value of vaccines and their contributions to the sustainable development goals, including the Value of Immunization Compendium of Evidence (VoICE) and the annual Pneumonia and Diarrhea Progress Report to provide advocates with evidence to drive change. My teaching focuses on vaccine policy and advocacy and I have trained hundreds of country-level professionals.

Prior to coming to Hopkins, I spent more than 15 years in the pharmaceutical industry working in a variety of commercial, operational, forecasting, market research and analysis, and R&D strategy roles in both human and animal health. I managed multiple strategies and initiatives for the launch of the first pneumococcal conjugate vaccine (PCV) in the US, and worked with countries in the Americas, Europe and the Middle East to introduce PCV, Hib vaccine and MenC vaccines.

  • vaccines
  • immunization policy
  • advocacy
  •  value of vaccines
  • vaccine hesitancy
  • India
  • low & middle income countries
  • adult vaccination
  • COVID-19
  • equity
  • global
  • Baltimore City
  • COVID-19 vaccination

Selected publications

  • Privor-Dumm, L. Poland G, Barratt, J., Durrheim, D., Knoll, M., Vasudevan, P., Jit, M., Bonvehi, P., Bonanni, P., on behalf of the International Council on Adult Immunization. (2020) A Global Agenda for Adult Immunization in the Era of COVID-19: A Roadmap for Action. Vaccine. In press. 10.1016/j.vaccine.2020.06.082
  • Privor-Dumm, L. Vasudevan, P., Kobayaski, K., Gupta, J. (2020) Archetype Analysis of Older Adult Immunization Decision-Making and Implementation in 34 countries Vaccine, 38(26): 4170-4182. 10.1016/j.vaccine.2020.04.027
  • Ozawa, S., Privor-Dumm, L. A., Nanni, A., Durden, E., Maiese, B. A., Nwankwo, C. U., . . . Foley, K. A. (2014). Evidence-to-policy gap on hepatitis A vaccine adoption in 6 countries: Literature vs. policymakers' beliefs. Vaccine, 32(32), 4089-4096. doi:10.1016/j.vaccine.2014.05.026
  • Hajjeh RA, Privor-Dumm L, Edmond K, O'Loughlin R, Shetty S, Griffiths UK, Bear AP, Cohen AL, Chandran A, Schuchat A, Mulholland EK, Santosham M. Supporting new vaccine introduction decisions: lessons learned from the Hib Initiative experience.  Vaccine. 2010 Oct 8;28(43):7123-9
  • Levine OS, Hajjeh R, Wecker J, Cherian T, O'Brien KL, Knoll MD, Privor-Dumm L, Kvist H, Nanni A, Bear AP, Santosham M. A policy framework for accelerating adoption of new vaccines. Hum Vaccin. 2010 Dec;6(12):1021-4

Update your faculty page